Alfonso Fernando, Fernández-Pérez Cristina, Del Prado Náyade, García-Guimaraes Marcos, Bernal José Luis, Bastante Teresa, Del Val David, García-Márquez María, Elola Javier
Department of Cardiology, Hospital Universitario de La Princesa, IIS-IP, CIBER-CV, Universidad Autónoma de Madrid, Madrid, Spain.
Department of Preventive Medicine, Área Sanitaria de Santiago de Compostela y Barbanza, Instituto de Investigación de Santiago, Santiago de Compostela, Spain.
Front Cardiovasc Med. 2022 Dec 1;9:1054413. doi: 10.3389/fcvm.2022.1054413. eCollection 2022.
Coronary revascularization in patients with spontaneous coronary artery dissection (SCAD) is challenging. Indications and results of percutaneous coronary interventions (PCI) in SCAD patients are not well established.
To assess indications and results of PCI in SCAD.
The minimum basic data set of the Spanish National Health System (years 2016-2019) was used to identify 804 episodes of acute myocardial infarction (AMI) and SCAD, with a crude in-hospital mortality rate of 3%. Of these, 368 (46.8%) patients were revascularized with PCI during admission whereas 436 (54.2%) were managed conservatively.
Revascularization and in-hospital mortality rates both declined over the study period (p for trend both < 0.05). SCAD patients treated with PCI were older, more frequently male, and had higher frequency of diabetes, ST-segment elevation AMI and cardiogenic shock, compared to patients managed conservatively. The crude in-hospital mortality rate was higher in patients treated with PCI (4.9% vs. 1.4%; = 0.004). However, after adjusting by propensity score (223 pairs) the in-hospital mortality rate was similar in the two groups (Adj OR: 1.21; 95%CI: 0.30-1.57; = 0.76). Readmissions at 30-days were higher in patients managed conservatively (7.1 vs. 1.6%, < 0.001) and this difference was maintained after propensity score adjustment (Adj average treatment effect: 2% vs. 12.2%; OR: 0.15; 95%CI: 0.04-0.45; < 0.001).
Revascularization is frequently used in unselected patients with AMI and SCAD but its use is declining. Patients with SCAD treated with PCI have a higher in-hospital mortality but this appears to be explained by their adverse baseline clinical characteristics.
自发性冠状动脉夹层(SCAD)患者的冠状动脉血运重建具有挑战性。SCAD患者经皮冠状动脉介入治疗(PCI)的适应症和结果尚未明确。
评估SCAD患者PCI的适应症和结果。
利用西班牙国家卫生系统的最小基本数据集(2016 - 2019年)识别出804例急性心肌梗死(AMI)和SCAD发作,住院粗死亡率为3%。其中,368例(46.8%)患者在入院期间接受了PCI血运重建,而436例(54.2%)患者接受了保守治疗。
在研究期间,血运重建率和住院死亡率均有所下降(趋势p值均<0.05)。与接受保守治疗的患者相比,接受PCI治疗的SCAD患者年龄更大,男性更常见,糖尿病、ST段抬高型AMI和心源性休克的发生率更高。接受PCI治疗的患者住院粗死亡率更高(4.9%对1.4%;p = 0.004)。然而,在按倾向评分进行调整后(223对),两组的住院死亡率相似(调整后OR:1.21;95%CI:0.30 - 1.57;p = 0.76)。保守治疗的患者30天再入院率更高(7.1%对1.6%,p < 0.001),且在倾向评分调整后这种差异仍然存在(调整后平均治疗效果:2%对12.2%;OR:0.15;95%CI:0.04 - 0.45;p < 0.001)。
血运重建在未选择的AMI和SCAD患者中经常使用,但使用频率正在下降。接受PCI治疗的SCAD患者住院死亡率更高,但这似乎是由其不良的基线临床特征所解释。